- Lobbying
- Lobbying by Patients Rising Now
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Chelsey Hickman | CoS, Rep. Kay Granger; LA Sen. Larry Craig CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig |
Donna Mullins | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
Nancy Fox | Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) |
Molly McDonnell | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
Mike Merola | Deputy CoS, Sen. Torricelli |
Charla Penn | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd |
Robert Zucker | LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Termination
Q4 Report
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Patient access to treatments and innovation.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate